Transient troponin elevations in the blood of healthy young children

Julia M Potter1, Gus Koerbin, Walter P Abhayaratna

  • 1Australian National University Medical School, Canberra, ACT 0200, Australia.

Insights

Cardiac troponin T (TnT) was detected in the blood of healthy children, with prevalence varying significantly between schools and years. This suggests transient, non-cardiac causes, possibly infective agents, may be responsible for detectable troponin levels.

Area of Science:

  • Pediatric Cardiology
  • Biomarker Research
  • Infectious Disease Epidemiology

Background:

  • Cardiac troponin is a marker of myocardial injury.
  • High-sensitivity troponin assays can detect lower concentrations.
  • Troponin may be present in healthy individuals.

Purpose of the Study:

  • To investigate the presence and prevalence of troponin T (TnT) in healthy children.
  • To explore variations in TnT levels within a pediatric cohort.

Main Methods:

  • Community-based prospective study of healthy children aged 8, 10, and 12 years.
  • Measurement of high-sensitivity troponin T (hs-TnT) in blood samples.
  • Analysis of 727 children with at least one blood sample collected.

Main Results:

  • Troponin was detected in 28.6% of healthy children across at least one sample.
  • Positive troponin detection rates ranged from 14.0% to 20.3% at different collection times.
  • Significant variation in troponin prevalence was observed between schools and across different years.

Conclusions:

  • Low concentrations of troponin can be transiently present in healthy children without cardiac injury.
  • The observed between-school and yearly variations suggest a potential transient infective agent.
  • Findings challenge the interpretation of troponin solely as a marker of cardiac necrosis in pediatric populations.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...